Literature DB >> 18395641

Respiratory failure following pulmonary resection.

Bernard J Park1.   

Abstract

Improvements in the perioperative management of the patient undergoing pulmonary resections have reduced postoperative complication rates steadily in the last several decades. However, postresection respiratory failure, particularly lung injury with no discernible cause, remains a major cause of morbidity and mortality. Because the incidence of this entity is relatively low, the terminology, pathogenesis, and optimal management are poorly delineated in the literature. The purpose of this review is to describe the criteria used to define postresection lung injury, discuss the possible etiologic factors, and outline currently available treatment strategies.

Entities:  

Mesh:

Year:  2007        PMID: 18395641     DOI: 10.1053/j.semtcvs.2007.10.003

Source DB:  PubMed          Journal:  Semin Thorac Cardiovasc Surg        ISSN: 1043-0679


  4 in total

1.  Influence of smoking on perioperative oxidative stress after pulmonary resection.

Authors:  Yoshimasa Mizuno; Hisashi Iwata; Hirotaka Yamamoto; Yusaku Miyamoto; Shohei Mitta; Koyo Shirahashi; Hirofumi Takemura
Journal:  Surg Today       Date:  2015-02-21       Impact factor: 2.549

Review 2.  Special article: the endothelial glycocalyx: emerging concepts in pulmonary edema and acute lung injury.

Authors:  Stephen R Collins; Randal S Blank; Lindy S Deatherage; Randal O Dull
Journal:  Anesth Analg       Date:  2013-07-08       Impact factor: 5.108

3.  Postoperative mortality is an inadequate quality indicator for lung cancer resection.

Authors:  Yinin Hu; Timothy L McMurry; Kristen M Wells; James M Isbell; George J Stukenborg; Benjamin D Kozower
Journal:  Ann Thorac Surg       Date:  2014-01-28       Impact factor: 4.330

4.  Increased reporting but decreased mortality associated with adverse events in patients undergoing lung cancer surgery: Competing forces in an era of heightened focus on care quality?

Authors:  Mitchell S von Itzstein; Arjun Gupta; Kemp H Kernstine; Kristin C Mara; Sahil Khanna; David E Gerber
Journal:  PLoS One       Date:  2020-04-09       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.